Securities code: Shandong Sito Bio-Technology Co.Ltd(300583) securities abbreviation: Shandong Sito Bio-Technology Co.Ltd(300583) Announcement No.: 2022010 Shandong Sito Bio-Technology Co.Ltd(300583) announcement of the resolution of the board of supervisors
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Shandong Sito Bio-Technology Co.Ltd(300583) the seventh meeting of the third session of the board of supervisors was held at 2:00 p.m. on April 5, 2022 in the company’s conference room in a combination of on-site and communication. The notice and documents of the meeting were sent to all supervisors and senior managers by e-mail on April 2, 2022. Three supervisors should attend the meeting, three supervisors actually attended the meeting, and the Secretary of the board of directors and some senior managers of the company attended the meeting as nonvoting delegates. The meeting was held in accordance with the company law of the people’s Republic of China and the articles of association.
The meeting was presided over by Ms. Zhang Wenxia, chairman of the board of supervisors. After careful deliberation and voting, all supervisors considered and adopted the following proposals:
The proposal on terminating the issue of A-Shares to specific objects in 2021 and withdrawing the application documents was deliberated and adopted
After discussion among the supervisors attending the meeting, the board of supervisors held that: in view of the changes in the current capital market environment and financing opportunities, combined with the actual situation of the company, future development planning and other factors, after careful analysis and repeated communication with intermediaries, the company decided to terminate the issue of shares to specific objects in 2021 and apply to Shenzhen stock exchange for withdrawal of relevant application documents. At present, all businesses of the company are operating normally. The termination of the issuance of shares to specific objects and the withdrawal of application documents will not have a significant adverse impact on the production and operation of the company, and there is no situation that damages the interests of the company and all shareholders, especially minority shareholders.
Voting results: 3 in favor, 0 against and 0 abstention, which was adopted.
According to the authorization of the company’s first extraordinary general meeting of shareholders in 2021, this proposal does not need to be submitted to the general meeting of shareholders for deliberation.
The specific contents of the announcement on terminating the issuance of A-Shares to specific objects in 2021 and withdrawing the application documents are detailed in the announcement of the company published on cninfo.com, the gem information disclosure website designated by the CSRC（ http://www.cn.info.com.cn. ）。
It is hereby announced.
Documents for future reference: resolution of the 7th Meeting of the Shandong Sito Bio-Technology Co.Ltd(300583) third board of supervisors Shandong Sito Bio-Technology Co.Ltd(300583) board of supervisors
April 6, 2002
